SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Chromatics Color Sciences International. Inc; CCSI -- Ignore unavailable to you. Want to Upgrade?


To: Dan Packer who wrote (1453)3/18/1998 5:20:00 PM
From: wlheatmoon  Read Replies (2) | Respond to of 5736
 
Dan,

Rotor Syndrome is a rare disorder where patients have a deficiency in organic anion uptake. They have an elevated total urinary coproporphyrin excretion and a relative increase in the amount of coproporphyrin I isomer. Additionally sulfabromophthalein excretion is often abnormal. It is an inherited conjugated hyperbilirubinemia disorder that rarely presents at birth. Their main problem is hyperbilirubinemia associated with stressful conditions, usually in their second decade and up. The bilirubinmeter may be helpful in determining the bilirubin level in these patients, but it's usually of no consequence.

Kernicterus is related to unbound bilirubin level, also known as unconjugated bilirubin. That's why I stated that initial care would probably require a confirmative blood test. Once the initial studies are done, followup can be done with the bilirubinmeter. The device can monitor total bilirubin levels and one can extrapolate the results based on the computer analysis.

I don't know what the cost of this monitoring will be. It doesn't matter. What matters is what the charge is going to be. That's a big difference. Tylenol costs a penny a piece, but the hospital charge you $3 a pill. This device will replace alot of studies. It will be reimbursed nicely. How much? I don't know. Whatever it is, it's better than having my babies get routine blood sticks.

Oh, don't forget the millions of chinese with hepatitis, all the liver failure patients here in the states due to alcohol, and my oh my, the market just seems to keep getting bigger.

Good luck shorting.

mike



To: Dan Packer who wrote (1453)3/18/1998 5:39:00 PM
From: JanyBlueEyes  Read Replies (1) | Respond to of 5736
 
You are obviously trying to confuse people using the medical terms you are throwing out.

It is really quite simple....here read it again....take your time....these words may be confusing to you.

Keep in mind this is from the FDA:

The Colormate III is to be used as an aid to the physician in MONITORING the status of newborn babies for the DEVELOPMENT of hyperbilirubinemia.

Following the physician's examination within the first hours of birth, newborn babies are initially measured and periodically monitored by the Colormate III for incremental changes in the yellow content of the skin color as compared to the baseline Colormate III measurements.

Babies with Colormate III test results indicative of hyperbilirubinemia are to be re-evaluated by the attending physician for appropriate patient management.